Activation of 5-HT receptors that stimulate the adenylyl cyclase pathway positively regulates IGF-I in cultured craniofacial mesenchymal cells

Developmental Neuroscience

Volumn 23, Issue 1, 2001, Pages 70-77

  Lambert, H Wayne ^a,b   Weiss, Ellen R ^a   Lauder, Jean M ^a,c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

5 HT1A; 5 HT4; cAMP; Embryonic development; Insulin like growth factor II; Insulin like growth factors; Isobutylmethylxanthine; Mandible; Mouse; Protein kinase inhibitor; Rp cAMPS

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 AMINO 5 CHLORO N [(HEXAHYDRO 1H PYRROLIZIN 1 YL)METHYL] 2 METHOXYBENZAMIDE; ADENYLATE CYCLASE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; SEROTONIN 1A RECEPTOR; SEROTONIN 4 RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; MANDIBLE; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

1-METHYL-3-ISOBUTYLXANTHINE; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ADENYLATE CYCLASE; ANIMALS; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME INHIBITORS; FORSKOLIN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INSULIN-LIKE GROWTH FACTOR I; MANDIBLE; MESODERM; MICE; PHOSPHODIESTERASE INHIBITORS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; THIONUCLEOTIDES;

EID: 0035108619     PISSN: 03785866     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048697     Document Type: Article

References (56)

1. 1A receptor
2. The presence of serotonin in animal sera used in cell culture
3. 7) positively linked to adenylate cyclase
4. Receptor-to-effector signaling through G proteins: Roles for βγ dimers as well as α subunits
5. 1A receptor in Sf9 cells
6. 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells
7. Induction of immunoreactive somatomedin C human serum by growth hormone: Dose-response relationships and effect on chromatographic profiles
8. Activation of a mitogen-activated protein kinase (ERK2) by the 5-hydroxytryptamine 1A receptor is sensitive not only to inhibitors of phosphatidylinositol 3-kinase, but to an inhibitor of phosphatidylcholine hydrolysis
9. Studies on the effect of insulin-like growth factor-I on catecholamine secretion from chromaffin cells
10. Insulin and insulin-like growth factors stimulate DNA synthesis in PC12 pheochromocytoma cells
11. Cytotactin: A morphoregulatory molecule and a target for regulation by homeobox gene products
12. 1A receptor
13. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay
14. 1MF-2 cells
15. Transcription factor AP-2 activity is modulated by protein kinase A-mediated phosphorylation
16. 1A receptor via a G protein beta gamma-subunit-initiated pathway
17. Characterization of the mouse insulin-like growth factor binding protein 4 gene regulatory region and expression studies
18. Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells
19. Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development
20. 2A receptor coupled to the Jak/STAT pathway
21. Chondrogenesis: A model developmental system for measuring teratogenic potential of compounds
22. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)
23. 3H]biotin
24. Induction of gene expression of the catecholamine-synthesizing enzymes by insulin-like growth factor-I
25. Protein kinase A coordinately regulates both basal expression and cyclic AMP-mediated induction of three catecholamine-synthesizing enzyme genes
26. Insulin-like growth factors and their binding proteins: Biological actions
27. 4
28. Signal transduction gene regulation: The nuclear response to cAMP
29. Serotonin receptor agonists that increase cyclic AMP positively regulate IGF-I in mouse mandibular mesenchymal cells
30. Neurotransmitters as morphogens
31. Neurotransmitters as growth regulatory signals: Role of receptors and second messengers
32. Serotonin in development and pathophysiology
33. 2B receptor
34. New evidence for neurotransmitter influences on brain development
35. i subtype specificity of the 5-HT1A receptor
36. Regulation of insulin-like growth factor I transcription by cyclic adenosine 3′,5′-monophosphate (cAMP) in fetal bone cells through an element within exon 1: Protein kinase A-dependent control without a consensus AMP response element
37. Pharmacological characterisation of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus
38. Serotonin regulates mouse cranial neural crest migration
39. Regulation of gene expression in cultured embryonic mouse mandibular mesenchyme by serotonin antagonists
40. Serotonin regulates tooth germ morphogenesis and gene expression in mouse mandibular explant cultures
41. The IGFs and their binding proteins in murine development
42. Short term feedback of cAMP in FRTL-5 thyroid cells
43. 7) activating cAMP formation
44. Serotonin receptors: Signal transduction pathways
45. 7 serotonin receptor subtype
46. Enhanced serotonin-stimulated adenylate cyclase activity in membranes from adult guinea pig hippocampus
47. Serotonin as a regulator of craniofacial morphogenesis: Site specific malformations following exposure to serotonin uptake inhibitors
48. Serotonin and morphogenesis: Transient expression of serotonin uptake and binding protein during craniofacial morphogenesis in the mouse
49. IGF-I-induced increase in matrix protein synthesis in rat mesangial cells is associated with CREB phosphorylation and a wortmannin-sensitive pathway
50. 2 in osteoblasts
51. 7 receptors: Current knowledge and future prospects
52. Why do neurotransmitters act like growth factors?
53. Gene-targeting and transgenic approaches to IGF and IGF binding protein function
54. The expression pattern of an insulin-like growth factor (IGF)-binding protein gene is distinct from IGF-II in the midgestational rat embryo
55. Targeted disruption of the IGFBP-2 gene
56. Serotonin uptake in the ectoplacental cone and placenta of the mouse